← Leaderboards
Tanya Marie Sandrock
Deltagen Proteomics, Inc.
$699,602
Attributed
$699,602
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300.3K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$699,602 · 2
By mechanism
R43$699,602 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Integrase Inhibitors”
- Alan N. Engelman · Dana-Farber Cancer Institute$20,794,509
- Mamuka Kvaratskhelia · University Of Colorado Denver$14,481,644
- Michael R. Farzan · Boston Children'S Hospital$13,950,923
- Geoffrey Scott Gottlieb · University Of Washington$13,091,394
- Peter G Stock · University Of California San Francisco$8,869,303
- Richard Douglas Moore · Johns Hopkins University$8,847,164
Research focus
Integrase InhibitorsIn VitroIntegraseBaseBinding (Molecular Function)Adverse Drug EffectCellsInhibitor/AntagonistCharacteristicsClinical TrialsComplexC-TerminalDna Binding DomainBiochemicalEnzymesExhibitsAqueousAids/Hiv ProblemGene DeletionGenetic TranscriptionHigh Throughput ScreeningHiv IntegraseHiv Integrase InhibitorsLacz Genes
Grant awards (3)
Technology for isolation of Integrase Inhibitors for Therapeutics against Human I$300,308
R43 · FY2010 · AI · contact PI
Technology for isolation of Integrase Inhibitors for Therapeutics against Human I$299,294
R43 · FY2009 · AI · contact PI
TECHNOLOGY FOR THERAPEUTICS AGAINST CERVICAL CARCINOMA$100,000
R43 · FY2000 · CA